Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL clinical trials

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

This study is testing a new medicine, inclisiran, to see if it can prevent serious heart problems like heart attacks and strokes in people who are at high risk but haven't had one before. They are comparing it to a dummy medicine.